KPCC Blogs

A case for expanding access to costly hepatitis C drugs

The newly approved Harvoni tablets bring several advances to the fight against hepatitis C, but they also have a steep price tag, reported at $1,125 for a single dose.

Two new analyses suggest that treating people during earlier stages of the disease saves insurers in the long run by avoiding expensive complications.

Introducing The Ride

The Ride -

There has been more change in how we get around in the past five years than in the prior 25, with ride sharing, electric and hybrid vehicles, expansion of biking and mass transit. Starting this Sunday, KPCC will be celebrating and exploring these changes through a four-part special called The Ride.